Vaxcyte, Inc. PCVX
5 trading plans running, 27 Form 144 notices for $13.9M
10-Q, 10-K and Form 144What PCVX's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From May 17, 2024 to Aug 15, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Harp Dhaliwal Chief Technical Operations Officer |
Adopted 10b5-1 plan | Apr 6, 2026 | 10-Q Aug 5, 2026 | ||
What the company wroteHarp Dhaliwal, our Chief Technical Operations Officer, adopted a 10b5-1 Plan on April 6, 2026, with an effective date of August 5, 2026. Mr. Dhaliwal’s 10b5-1 Plan provides for the potential exercise and sale of up to 68,000 shares of our common stock, and expires on August 15, 2027, or upon the earlier completion of all authorized transactions thereunder. | |||||
| Andrew Guggenhime President and Chief Financial Officer |
Adopted 10b5-1 plan | Mar 4, 2026 | 10-Q May 6, 2026 | ||
What the company wroteAndrew Guggenhime, our President and Chief Financial Officer, adopted a 10b5-1 Plan on March 4, 2026, with an effective date of June 3, 2026. Mr. Guggenhime’s 10b5-1 Plan provides for the potential exercise and sale of up to 156,000 shares of our common stock, and expires on June 30, 2027, or upon the earlier completion of all authorized transactions thereunder. | |||||
| Grant Pickering Chief Executive Officer and a member of our Board |
Adopted 10b5-1 plan | Mar 3, 2026 | 10-Q May 6, 2026 | ||
| Jim Wassil Executive Vice President, Chief Operating Officer |
Adopted 10b5-1 plan | Dec 9, 2025 | 10-K Feb 24, 2026 | ||
What the company wroteJim Wassil, our Executive Vice President, Chief Operating Officer, adopted a 10b5-1 Plan on December 9, 2025, with an effective date of March 10, 2026. Mr. Wassil’s 10b5-1 Plan provides for the potential exercise and sale of up to 70,056 shares of our common stock, and expires on March 1, 2027, or upon the earlier completion of all authorized transactions thereunder. | |||||
| Elvia Cowan Senior Vice President of Finance and Principal Accounting Officer |
Adopted 10b5-1 plan | Dec 8, 2025 | 10-K Feb 24, 2026 | ||
What the company wroteElvia Cowan, our Senior Vice President of Finance and Principal Accounting Officer, adopted a 10b5-1 Plan on December 8, 2025, with an effective date of March 10, 2026. Ms. Cowan’s 10b5-1 Plan provides for the potential exercise and sale of up to 41,060 shares of our common stock, and expires on February 28, 2027, or upon the earlier completion of all authorized transactions thereunder. | |||||
| Peter Hirth member of our Board |
Ended 10b5-1 plan | May 28, 2025 | 10-Q Aug 6, 2025 | ||
What the company wroteOn May 28, 2025, Peter Hirth, who was a member of our Board at the time, terminated his 10b5-1 Plan. Dr. Hirth's 10b5-1 Plan was originally adopted on December 6, 2024, with an effective date of March 7, 2025, for the potential exercise and sale of up to 13,200 shares of our common stock until March 31, 2026, or upon the earlier completion of all authorized transactions thereunder. | |||||
| Andrew Guggenhime President and Chief Financial Officer |
Ended 10b5-1 plan | Mar 17, 2025 | 10-Q May 7, 2025 | ||
What the company wroteAndrew Guggenhime, our President and Chief Financial Officer, terminated his 10b5-1 Plan on March 17, 2025. Mr. Guggenhime’s 10b5-1 Plan was originally adopted on May 17, 2024, with an effective date of October 18, 2024, for the potential exercise and sale of up to 146,000 shares of our common stock, until October 17, 2025, or upon the earlier completion of all authorized transactions thereunder. | |||||
| Grant Pickering Chief Executive Officer |
Ended 10b5-1 plan | Dec 31, 2024 | 10-K Feb 25, 2025 | ||
What the company wroteGrant Pickering, our Chief Executive Officer and a member of our Board, terminated his 10b5-1 Plan on December 31, 2024. Mr. Pickering’s 10b5-1 Plan was originally adopted on April 12, 2024 for the potential sale of (i) up to 45,000 shares of our common stock held by Mr. Pickering and the potential exercise and sale of up to 195,000 shares of our common stock held by Mr. Pickering, and (ii) up to 35,490 shares of our common stock held by trusts in which the beneficiaries are children of Mr. Pickering, until October 1, 2025, or upon the earlier completion of all authorized transactions thereunder. | |||||
| Peter Hirth member of our Board |
Adopted 10b5-1 plan | Dec 6, 2024 | 10-K Feb 25, 2025 | ||
What the company wrotePeter Hirth, a member of our Board, adopted a 10b5-1 Plan on December 6, 2024, with an effective date of March 7, 2025. Dr. Hirth’s 10b5-1 Plan provides for the potential exercise and sale of up to 13,200 shares of our common stock, and expires on March 31, 2026, or upon the earlier completion of all authorized transactions thereunder. | |||||
| Elvia Cowan Senior Vice President of Finance and Principal Accounting Officer |
Adopted 10b5-1 plan | Sep 27, 2024 | 10-Q Nov 5, 2024 | ||
| Teri Loxam member of our Board |
Adopted 10b5-1 plan | Jun 18, 2024 | 10-Q Aug 6, 2024 | ||
What the company wroteTeri Loxam, a member of our Board, adopted a 10b5-1 Plan on June 18, 2024, with an effective date of September 16, 2024. Ms. Loxam’s 10b5-1 Plan provides for the potential exercise and sale of up to 12,500 shares of our common stock, and expires on September 15, 2025, or upon the earlier completion of all authorized transactions thereunder. | |||||
| Halley Gilbert member of our Board |
Ended 10b5-1 plan | Jun 16, 2024 | 10-Q Aug 6, 2024 | ||
What the company wroteHalley Gilbert, a member of our Board, terminated her 10b5-1 Plan on June 16, 2024. Ms. Gilbert’s 10b5-1 Plan was originally adopted on March 1, 2024 for the potential exercise and sale of up to 51,950 shares of our common stock until May 31, 2025, or upon the earlier completion of all authorized transactions thereunder. | |||||
| Mikhail Eydelman General Counsel, Chief Compliance Officer |
Adopted 10b5-1 plan | Jun 11, 2024 | 10-Q Aug 6, 2024 | ||
What the company wroteMikhail Eydelman, our General Counsel, Chief Compliance Officer and Corporate Secretary, adopted a 10b5-1 Plan on June 11, 2024, with an effective date of October 1, 2024. Mr. Eydelman’s 10b5-1 Plan provides for the potential exercise and sale of up to 65,500 shares of our common stock, and expires on September 30, 2025, or upon the earlier completion of all authorized transactions thereunder. | |||||
| Andrew Guggenhime President and Chief Financial Officer |
Adopted 10b5-1 plan | May 17, 2024 | 10-Q Aug 6, 2024 | ||
What the company wroteAndrew Guggenhime, our President and Chief Financial Officer, adopted a 10b5-1 Plan on May 17, 2024, with an effective date of October 18, 2024. Mr. Guggenhime’s 10b5-1 Plan provides for the potential exercise and sale of up to 146,000 shares of our common stock, and expires on October 17, 2025, or upon the earlier completion of all authorized transactions thereunder. | |||||
| Grant Pickering Chief Executive Officer and a member of our Board |
Adopted 10b5-1 plan | Apr 12, 2024 | 10-Q Aug 6, 2024 | ||
What the company wroteGrant Pickering, our Chief Executive Officer and a member of our Board, adopted a 10b5-1 Plan on April 12, 2024, with an effective date of October 1, 2024. Mr. Pickering’s 10b5-1 Plan provides for the potential sale of up to 45,000 shares of our common stock held by Mr. Pickering and the potential exercise and sale of up to 195,000 shares of our common stock held by Mr. Pickering. Mr. Pickering’s 10b5-1 Plan also provides for the potential sale of up to 35,490 shares of our common stock held by trusts in which the beneficiaries are children of Mr. Pickering. Mr. Pickering's 10b5-1 Plan expires on October 1, 2025, or upon the earlier completion of all authorized transactions thereunder. | |||||
| Halley Gilbert Board and Audit Committee member |
Adopted 10b5-1 plan | Mar 1, 2024 | 10-Q May 8, 2024 | ||
What the company wroteHalley Gilbert, our Board and Audit Committee member, adopted a 10b5-1 Plan on March 1, 2024. Ms. Gilbert’s 10b5-1 Plan provides for the potential exercise and sale of up to 51,950 shares of our common stock, and expires on May 31, 2025, or upon the earlier completion of all authorized transactions thereunder. | |||||
| Jim Wassil Chief Operating Officer |
Adopted 10b5-1 plan | Mar 1, 2024 | 10-Q May 8, 2024 | ||
What the company wroteJim Wassil, our Chief Operating Officer, adopted a 10b5-1 Plan on March 1, 2024. Mr. Wassil’s 10b5-1 Plan provides for the potential exercise and sale of up to 108,000 shares of our common stock, and expires on September 1, 2025, or upon the earlier completion of all authorized transactions thereunder. | |||||
| Andrew Guggenhime President and Chief Financial Officer |
Adopted 10b5-1 plan | Jun 30, 2023 | 10-Q Aug 8, 2023 | ||
| Mikhail Eydelman Senior Vice President, General Counsel and Corporate Secretary |
Adopted 10b5-1 plan | Jun 29, 2023 | 10-Q Aug 8, 2023 | ||
| Grant E. Pickering Chief Executive Officer and a member of our Board |
Adopted 10b5-1 plan | Jun 26, 2023 | 10-Q Aug 8, 2023 | ||
| Jim Wassil Executive Vice President and Chief Operating Officer |
Adopted 10b5-1 plan | May 23, 2023 | 10-Q Aug 8, 2023 | ||
| Heath Lukatch member of our Board |
Adopted 10b5-1 plan | May 11, 2023 | 10-Q Aug 8, 2023 | ||
Show the other 14 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 8, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Nov 12, 2026 | Dhaliwal Harpreet S. Officer |
17,000 | $1.2M |
| Nov 2, 2026 | Wassil Jim Officer |
2,250 | $139K |
| Nov 2, 2026 | Cowan Elvia Officer |
3,000 | $186K |
| Oct 5, 2026 | Cowan Elvia Officer |
19,000 | $1.6M |
| Oct 5, 2026 | Wassil Jim Officer |
18,000 | $1.6M |
| Oct 1, 2026 | Wassil Jim Officer |
2,250 | $128K |
| Sep 9, 2026 | Wassil Jim Officer |
1,334 | $80K |
| Sep 4, 2026 | Wassil Jim Officer |
1,381 | $82K |
| Sep 1, 2026 | Wassil Jim Officer |
3,477 | $210K |
| Aug 5, 2026 | Dhaliwal Harpreet S. Officer |
17,000 | $935K |
| Aug 3, 2026 | GUGGENHIME ANDREW Officer |
10,000 | $540K |
| Aug 3, 2026 | Wassil Jim Officer |
2,250 | $121K |
| Jul 27, 2026 | PICKERING GRANT Officer, Director |
18,198 | $997K |
| Jul 6, 2026 | GUGGENHIME ANDREW Officer |
10,000 | $578K |
| Jul 1, 2026 | Wassil Jim Officer |
2,250 | $131K |
| Jun 26, 2026 | PICKERING GRANT Officer, Director |
24,237 | $1.3M |
| Jun 18, 2026 | GUGGENHIME ANDREW Officer |
10,000 | $530K |
| Jun 18, 2026 | PICKERING GRANT Officer |
24,461 | $1.3M |
| Jun 1, 2026 | Wassil Jim Officer |
2,250 | $115K |
| May 1, 2026 | Wassil Jim Officer |
2,250 | $129K |
| Apr 7, 2026 | Cowan Elvia Officer |
3,000 | $180K |
| Apr 1, 2026 | Wassil Jim Officer |
2,250 | $131K |
| Mar 17, 2026 | Cowan Elvia Officer |
1,892 | $106K |
| Mar 11, 2026 | Cowan Elvia Officer |
2,500 | $147K |
| Mar 10, 2026 | Wassil Jim Officer |
7,395 | $432K |
| Dec 31, 2025 | HARPREET DHALIWAL Officer |
9,743 | $455K |
| Dec 23, 2025 | ELVIA COWAN Officer |
11,623 | $557K |
Show the other 19 notices
From the Form 144 XML filed with the SEC, since Dec 23, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PCVX/export.csv") into a cell.